Pharmacy and Therapeutics Committee
Dedicated clinicians who inform pharmacy decisions based on efficacy, evidence and empathy
The mission of the Rx Savings Solutions Pharmacy and Therapeutics (P&T) Committee is to provide safe, quality and cost-effective drug information for RxSS members and clients.
DID YOU KNOW?
Covering more than 18 million members, the RxSS P&T Committee oversees more lives than all but the four largest health plans in the U.S., just behind the Centers for Medicare & Medicaid Services (CMS).
Total number of active suggestions
0 +
Unique products with suggestions
0
Average number of suggestions per product
0
Total number of active suggestions
0
Unique products with suggestions
0
Average number of suggestions per product
0
Total number of active suggestions
0
Unique products with suggestions
0
Average number of suggestions per product
0
MEET THE P&T Committee VOTING MEMBERS
Vice President, Pharmacy Retail Operations – McKesson
our purpose
The P&T Committee maintains the RxSS database of clinical suggestions to promote safety, efficacy and advance the company mission.
ENSURE
Ensure compliance with clinical standards of care using appropriate drug compendia, national guidelines and emerging pharmacological data.
REVIEW
Review new drugs, therapeutic classes, clinical indications, therapeutic advantages and safety information.
EVALUATE
Evaluate outcomes from member prescription change requests and analyze prescriber acceptance/denial rates.
ENSURE
Ensure compliance with clinical standards of care using appropriate drug compendia, national guidelines and emerging pharmacological data.
REVIEW
Review new drugs, therapeutic classes, clinical indications, therapeutic advantages and safety information.
EVALUATE
Evaluate outcomes from member prescription change requests and analyze prescriber acceptance/denial rates.
OUR CRITERIA
In addition to peer-reviewed, evidence-based and fully referenced drug compendia, the P&T Committee curates savings suggestions based on one, final litmus test: Would we recommend this to our family?
Maximize safety and limit risk when evaluating the potential savings benefit of a suggested product compared with a current treatment.
Show only suggestions with equivalent efficacy or recommended alternatives.
Limit the risk of member confusion when mapping products with multiple alternatives while also aligning with reasonable standards of care.
What is more likely to increase a member’s adherence—cost or convenience? We show options that check the box for both to help members stay on track with prescribed treatments.
In general, we will suggest any existing clinically appropriate alternative, giving preference to more commonly utilized cost-effective options.
